SCHEMBL6943199

SCHEMBL6943199

C[C@@H](SC(CO)CO)[C@](O)(Cn1cncn1)c1cccc(F)c1F

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 12/20 0.43
CYP2C9 P11712 10/20 0.43
CYP2C19 P33261 10/20 0.43
LMNA P02545 2/20 0.43
CYP2B6 P20813 1/20 0.43
CYP3A5 P20815 1/20 0.43
CYP3A7 P24462 1/20 0.43
MAPK1 P28482 1/20 0.43
CYP3A43 Q9HB55 1/20 0.43
CYP46A1 Q9Y6A2 1/20 0.43
HSP90AA1 P07900 2/20 0.41
CYP19A1 P11511 1/20 0.41
CYP11B1 P15538 1/20 0.41
CYP11B2 P19099 1/20 0.41
ADRA1A P35348 1/20 0.41
CYP51A1 Q16850 1/20 0.41
CYP1A2 P05177 6/20 0.40
CYP2D6 P10635 6/20 0.40
KCNH2 Q12809 3/20 0.37
ABCG2 Q9UNQ0 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6946209 0.92 CYP3A4 (0.46) CYP3A4CYP2C9CYP2C19LMNACYP2B6
SCHEMBL21405667 0.83 CYP3A4 (0.47) CYP3A4CYP2C9CYP2C19LMNACYP2B6
SCHEMBL21405666 0.83 CYP3A4 (0.47) CYP3A4CYP2C9CYP2C19LMNACYP2B6
SCHEMBL4683648 0.83 CYP3A4 (0.62) CYP3A4CYP2C9CYP2C19LMNACYP2B6
SCHEMBL6939603 0.83 CYP3A4 (0.52) CYP3A4CYP2C9CYP2C19LMNACYP2B6
SCHEMBL10833327 0.81 CYP3A4 (0.48) CYP3A4CYP2C9CYP2C19LMNACYP2B6
SCHEMBL6945044 0.81 KMT2A (0.51) CYP3A4CYP2C9CYP2C19LMNACYP2B6
SCHEMBL21405675 0.76 CYP3A4 (0.45) CYP3A4CYP2C9CYP2C19LMNACYP2B6
SCHEMBL21405676 0.76 CYP3A4 (0.45) CYP3A4CYP2C9CYP2C19LMNACYP2B6
SCHEMBL8664843 0.76 CYP3A4 (0.51) CYP3A4CYP2C9CYP2C19LMNACYP2B6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1083175-B1 Triazole derivatives having antifungal activity SANKYO CO (JP) 2003-07-02 EP disclosed
US-6392082-B1 CHEMICAL INTERMEDIATE SANKYO COMPANY, LIMITED (JP) 2002-05-21 US disclosed
US-6391903-B1 THERAPY FOR FUNGI INFECTIONS SANKYO COMPANY, LIMITED (JP) 2002-05-21 US disclosed
US-6337403-B1 CRYSTALLINE FORM OF A PHARMACEUTICAL COMPOSITION CONTAINING SAID DERIVATIVES WITH TREATING AND PREVENTING FUNGAL INFECTIONS USING BUTADIENE FLUORO BENZONITRILE GROUPS SANKYO COMPANY, LIMITED (JP) 2002-01-08 US disclosed
EP-1083175-A2 Triazole derivatives having antifungal activity Sankyo Company Limited (JP) 2001-03-14 EP disclosed